Skip to main content
. 2023 Dec 1;8(5):1322–1327. doi: 10.1182/bloodadvances.2023011798

Table 2.

Response rates and hematologic values in patients receiving rEPO vs the comparison population

rEPO (N = 47) No rEPO (N = 43)
Baseline
 Hb g/dL, mean (SD) 7.6 (1.7) 7.8 (1.4)
 Transfusions (%) 14 (30) 15 (35)
15 d 47 43
 ORR (%) - CR/PR 26 (55) - 3/23 14 (32) - 1/3
 Hb g/dL, mean (SD) 9.5 (1.5) 8.8 (1.5)
 Transfusions (%) 4 (9) 7 (15)
1 mo 47 43
 ORR (%) - CR/PR 35 (74) - 10/25 25 (58) - 4/21
 Hb g/dL, mean (SD) 10.5 (1.9) 9.8 (1.5)
 Transfusions (%) 3 (6) 4 (9)
3 mo 47 43
 ORR (%) - CR/PR 35 (74) - 19/16 30 (69)- 12/18
 Hb g/dL, mean (SD) 11.2 (1.9) 10.8 (1.9)
 Transfusions (%) 2 (4) 1 (2)
6 mo 44 42
 ORR (%) - CR/PR 35 (80) - 22/13 30 (71) - 13/17
 Hb g/dL, mean (SD) 11.3 (2.1) 10.8 (1.8)
 Transfusions (%) 3 (7) 2 (5)
12 mo 34 39
 ORR (%) - CR/PR 31 (91) - 25/6 29 (74) - 13/16
 Hb g/dL, mean (SD) 12.1 (1.4) 11.1 (2)
 Transfusions (%) 0 (0) 1 (3)

CR, complete response; PR, partial response; SD, standard deviation.

P < .05.